Patient No. | Group No. | Patient Age | Tumor1 Size | Tumor Grade | Positive2 Nodes | ER | PR | Her2 | FNAB RIN | FFPE RIN |
---|---|---|---|---|---|---|---|---|---|---|
1 | E(+)H(-)-1 | 56 | 1.2 | 2 | 0(1) | + | + | - | 7.5 | 1.7 |
2 | E(+)H(-)-2 | 47 | 2.2 | 2 | 1(12) | + | + | - | 9.2 | 2.3 |
3 | E(+)H(-)-3 | 63 | 2.4 | 2 | 0(1) | + | + | - | 7.0 | 2.5 |
4 | E(+)H(-)-4 | 76 | 2.8 | 3 | 0(3) | + | + | - | 8.9 | 2.5 |
5 | E(+)H(-)-5 | 58 | 10.6 | 2 | 6(24) | + | + | - | 6.6 | 2.5 |
6 | E(+)H(-)-6 | 50 | 3.7 | 2 | 0(2) | + | + | - | 8.6 | 2.4 |
7 | E(+)H(-)-7 | 55 | 1.9 | 2 | 2(15) | + | + | - | 9.4 | 1.5 |
8 | E(+)H(-)-8 | 68 | 2.0 | 2 | 4(17) | + | + | - | 7.2 | 2.7 |
9 | E(+)H(-)-9 | 42 | 2.6 | 2 | 0(3) | + | + | - | 7.8 | 2.3 |
10 | E(+)H(-)-10 | 64 | 1.5 | 2 | 0(4) | + | + | - | 7.4 | 2.1 |
11 | E(+)H(+)-1 | 61 | 2.2 | 3 | 2(18) | + | - | + | 8.3 | 2.4 |
12 | E(+)H(+)-2 | 43 | 2.5 | 3 | 0(5) | + | - | + | 7.9 | 2.4 |
13 | E(+)H(+)-3 | 41 | 1.6 | 3 | 0(3) | + | + | + | 9.3 | 2.2 |
14 | E(+)H(+)-4 | 37 | 1.5 | 3 | 0(18) | + | + | + | 9.0 | 2.1 |
15 | E(-)H(+)-1 | 44 | 3.2 | 3 | 0(1) | - | - | + | 6.7 | 2.7 |
16 | E(-)H(+)-2 | 56 | 1.4 | 3 | 0(3) | - | - | + | 6.9 | 1.9 |
17 | E(-)H(+)-3 | 76 | 2.3 | 3 | 2(20) | - | - | + | 5.6 | 2.3 |
18 | E(-)H(+)-4 | 64 | 2.3 | 3 | 5(21) | - | - | + | 8.8 | 2.2 |
19 | E(-)H(+)-5 | 73 | 1.6 | 3 | 0(2) | - | - | + | 6.5 | 2.4 |
20 | E(-)H(+)-6 | 54 | 2.9 | 3 | 0(12) | - | - | + | 8.0 | 2.5 |
21 | E(-)H(-)-1 | 51 | 1.6 | 3 | 1(23) | - | - | - | 8.3 | 1.7 |
22 | E(-)H(-)-2 | 54 | 3.6 | 2 | 0(11) | - | - | - | 6.9 | 2.4 |
23 | E(-)H(-)-3 | 62 | 1.6 | 3 | 1(21) | - | - | - | 6.6 | 2.4 |
24 | E(-)H(-)-4 | 47 | 1.5 | 3 | 0(4) | - | - | - | 5.6 | 2.3 |
25 | E(-)H(-)-5 | 57 | 2.9 | 2 | 0(4) | - | - | - | 8.9 | 2.2 |